Literature DB >> 7751009

Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated gamma delta T-cell-depleted mice.

S Nabeshima1, K Hiromatsu, G Matsuzaki, A Mukasa, H Takada, S Yoshida, K Nomoto.   

Abstract

To evaluate the hypothesis that gamma delta T cells participate in protective immunity against mycobacterial infection, we depleted gamma delta T cells from mice by administration of anti-T-cell receptor (TCR)gamma delta monoclonal antibody (mAb) and analysed protection against Mycobacterium bovis bacillus Calmette-Guérin (BCG). The gamma delta T-cell-depleted mice did not show any exaggerated bacterial multiplication compared with control mice. In contrast, alpha beta T-cell-depleted mice, which were administrated anti-TCR alpha beta mAb before BCG infection, showed a depressed protective immunity. These results suggest that gamma delta T cells are not essential for coping with a primary BCG infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751009      PMCID: PMC1415094     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Kinetics of accumulation of gamma delta receptor-bearing T lymphocytes in mice infected with live mycobacteria.

Authors:  J P Griffin; K V Harshan; W K Born; I M Orme
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 2.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.

Authors:  A M Dannenberg
Journal:  Immunol Today       Date:  1991-07

3.  Sequential appearance of gamma/delta- and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes.

Authors:  S Ohga; Y Yoshikai; Y Takeda; K Hiromatsu; K Nomoto
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

4.  Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.

Authors:  T Inoue; Y Yoshikai; G Matsuzaki; K Nomoto
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

5.  A lectin-binding, protease-resistant mycobacterial ligand specifically activates V gamma 9+ human gamma delta T cells.

Authors:  K Pfeffer; B Schoel; N Plesnila; G B Lipford; S Kromer; K Deusch; H Wagner
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

6.  Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis.

Authors:  D V Havlir; J J Ellner; K A Chervenak; W H Boom
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein.

Authors:  D Kabelitz; A Bender; S Schondelmaier; B Schoel; S H Kaufmann
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

8.  A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice.

Authors:  K Hiromatsu; Y Yoshikai; G Matsuzaki; S Ohga; K Muramori; K Matsumoto; J A Bluestone; K Nomoto
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Quest for correlates of protection against tuberculosis.

Authors:  Kamlesh Bhatt; Sheetal Verma; Jerrold J Ellner; Padmini Salgame
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

Review 2.  It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity.

Authors:  Sasha E Larsen; Brittany D Williams; Maham Rais; Rhea N Coler; Susan L Baldwin
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.